|
Market Closed -
Nasdaq
20:00:00 27/10/2026 GMT
|
5-day change | 1st Jan Change | ||
| 2.040 USD | -0.49% |
|
-11.30% | -43.49% |
| 10-27 | Altimmune, Inc. Announces Board Changes | CI |
| 09-30 | Weight-loss drug developers line up to tap lucrative market as competition heats up | RE |
Main competitors
| Change | 5-day change | 1-month change | 3-month change | YTD change | 1-year change | 3-year change | 5-year change | 10-year change | Capi.($) | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
 | -0.49% | -11.30% | -33.33% | -31.08% | -43.49% | -50.72% | -11.69% | -81.45% | - | 397M | |
| -3.10% | -4.19% | -12.88% | +13.49% | +56.09% | +32.67% | +59.47% | +4.36% | - | 63.48B | |
| +0.33% | +0.33% | -7.38% | -0.89% | +9.21% | +10.16% | +78.07% | +225.62% | +5,451.77% | 54.55B | |
| +0.16% | +1.73% | +11.70% | +13.66% | +18.22% | +9.89% | +102.10% | -15.79% | +259.62% | 53.59B | |
| -0.75% | +1.38% | +0.44% | +27.36% | +20.47% | +24.89% | +50.91% | +6.79% | +276.63% | 44.75B | |
| -1.30% | -4.80% | +1.44% | +12.32% | +20.49% | +16.05% | +114.76% | -0.33% | +1,015.68% | 41.62B | |
| +1.26% | -5.26% | -9.15% | -0.98% | +133.80% | +221.12% | +900.64% | +574.95% | - | 39.91B | |
| -0.74% | -4.46% | +6.31% | +5.54% | +9.41% | +11.00% | +44.65% | +4.75% | +151.07% | 32.47B | |
| +1.11% | +15.18% | +31.62% | +57.08% | +47.85% | +60.27% | +49.33% | +3.20% | +162.43% | 26.7B | |
| +3.72% | -6.36% | -13.37% | +19.91% | +47.14% | +25.84% | -8.40% | -59.84% | - | 23.36B | |
| +0.23% | -4.51% | -11.63% | -4.42% | -8.55% | -17.91% | -4.54% | -68.77% | - | 21.87B | |
| +1.75% | -0.74% | -19.41% | -9.33% | -45.44% | -42.10% | +297.65% | +259.70% | +590.12% | 20.74B | |
| -0.44% | +8.25% | +8.87% | +14.32% | +19.97% | +12.96% | +169.21% | +219.94% | +2,244.43% | 18.85B | |
| +0.44% | +13.75% | +22.54% | +59.98% | +79.89% | +83.76% | +107.91% | -16.56% | +369.19% | 17.13B | |
| -0.58% | +8.20% | +10.50% | +27.73% | +36.99% | +38.81% | +84.70% | -16.52% | +107.58% | 16.53B | |
| +0.37% | +1.49% | +12.36% | +17.09% | +49.10% | +63.42% | +223.51% | +206.81% | +498.44% | 16.19B | |
| +0.29% | +4.92% | +8.98% | -2.99% | - | - | - | - | - | 16.15B | |
| +2.59% | +3.03% | +3.03% | -0.42% | +180.86% | +161.39% | +341.90% | +1,405.54% | +779.81% | 15.21B | |
| -3.88% | -8.20% | -4.57% | -14.57% | +10.76% | +2.99% | +431.05% | - | - | 13.81B | |
| -0.44% | +5.05% | +6.18% | +8.41% | +0.42% | +0.52% | -22.24% | -35.05% | +127.36% | 14.12B | |
| Average | +0.01% | +0.62% | +0.61% | +10.61% | +33.85% | +35.00% | +158.37% | +145.41% | +925.70% | 27.57B | |
| Weighted average by Cap. | -0.18% | +0.14% | +0.60% | +12.69% | +36.88% | +39.05% | +160.74% | +125.58% | +1,233.88% |
- Stock Market
- Stocks
- ALT Stock
- Sector Altimmune, Inc.
Select your edition
All financial news and data tailored to specific country editions
